SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027013
Filing Date
2023-08-03
Accepted
2023-08-03 07:44:08
Documents
57
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q itci-20230630.htm   iXBRL 10-Q 796634
2 EX-31.1 itci-20230630xex311.htm EX-31.1 9631
3 EX-31.2 itci-20230630xex312.htm EX-31.2 9648
4 EX-32 itci-20230630xex32.htm EX-32 5430
  Complete submission text file 0001628280-23-027013.txt   4398080

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20230630.xsd EX-101.SCH 28159
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20230630_cal.xml EX-101.CAL 49220
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20230630_def.xml EX-101.DEF 133375
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20230630_lab.xml EX-101.LAB 492987
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20230630_pre.xml EX-101.PRE 297555
51 EXTRACTED XBRL INSTANCE DOCUMENT itci-20230630_htm.xml XML 505559
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 231138112
SIC: 2834 Pharmaceutical Preparations